Sydenham's chorea: a clinical follow-up of 65 patients

Kaan Demiroren1, Haluk Yavuz, Lokman Cam

  • 1Department of Pediatrics, Cagri Tip Merkezi, Elazig, Turkey. kaandemiroren@yahoo.com

Insights

Sydenham's chorea, a childhood rheumatic fever complication, affects many children. This study details clinical findings, treatment, and outcomes, highlighting its continued impact.

Area of Science:

  • Neurology
  • Pediatrics
  • Rheumatology

Background:

  • Sydenham's chorea is the most common acquired chorea in childhood, linked to rheumatic fever.
  • It presents as a neurological manifestation requiring clinical and laboratory assessment.

Purpose of the Study:

  • To present clinical and laboratory findings of Sydenham's chorea patients.
  • To analyze patient demographics, symptoms, cardiac involvement, and treatment outcomes.

Main Methods:

  • Retrospective study of 65 Sydenham's chorea patients over 7 years.
  • Data collected included age of onset, gender, chorea presentation, medical history, echocardiography, MRI, EEG, and treatment.

Main Results:

  • Mean onset age 11.7 years; 63% female. Generalized chorea seen in 78.5%.
  • Rheumatic fever history in 30.8%; cardiac valve involvement in 70.5%. EEG abnormal in 50%.
  • Pimozide was a common treatment; 18.5% needed no drugs. Recovery took 1-6 months for 51.7%. Recurrence rate was 37.9%.

Conclusions:

  • Sydenham's chorea remains a significant health concern in Turkey due to its morbidity.
  • Early diagnosis and management are crucial for improving patient outcomes and reducing long-term complications.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...